Isracann Biosciences Stock Price on September 11, 2024
If you're considering investing in Isracann Pink Sheet, it is important to understand the factors that can impact its price. Isracann Biosciences holds Efficiency (Sharpe) Ratio of -0.13, which attests that the entity had a -0.13% return per unit of risk over the last 3 months. Isracann Biosciences exposes zero different technical indicators, which can help you to evaluate volatility embedded in its price movement.
Isracann Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.
Isracann |
Sharpe Ratio = -0.126
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ISCNF |
Estimated Market Risk
| 12.6 actual daily | 96 96% of assets are less volatile |
Expected Return
| -1.59 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.13 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Isracann Biosciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Isracann Biosciences by adding Isracann Biosciences to a well-diversified portfolio.
Isracann Biosciences Valuation on September 11, 2024
It is possible to determine the worth of Isracann Biosciences on a given historical date. On September 11, 2024 Isracann was worth 1.0E-4 at the beginning of the trading date compared to the closed value of 1.0E-4. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Isracann Biosciences pink sheet. Still, in general, we apply an absolute valuation method to find Isracann Biosciences' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Isracann Biosciences where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Isracann Biosciences' related companies.
| Open | High | Low | Close | Volume | |
| 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
09/11/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 |
| 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 |
| Backtest Isracann Biosciences | | | Isracann Biosciences History | | | Isracann Biosciences Valuation | Previous | Next |
Isracann Biosciences Trading Date Momentum on September 11, 2024
| On September 12 2024 Isracann Biosciences was traded for 0.0001 at the closing time. The highest daily price throughout the period was 0.0001 and the lowest price was 0.0001 . There was no trading activity during the period 1.0. Lack of trading volume on 09/12/2024 did not cause price change. The trading delta at closing time to current closing price is 0.00% . |
Isracann Biosciences Fundamentals Correlations and Trends
By evaluating Isracann Biosciences' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Isracann Biosciences' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Isracann financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Isracann Biosciences Pink Sheet history
Isracann Biosciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Isracann is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Isracann Biosciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Isracann Biosciences stock prices may prove useful in developing a viable investing in Isracann Biosciences
Isracann Biosciences Inc., together with its subsidiaries, cultivates and distributes medical cannabis in Israel. Isracann Biosciences Inc. was founded in 2010 and is headquartered in Vancouver, Canada. Isracann Biosciences is traded on OTC Exchange in the United States.
Isracann Biosciences Pink Sheet Technical Analysis
Isracann Biosciences technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Price Boundaries
Isracann Biosciences Period Price Range
Low | December 1, 2024
| High |
0.00 | 0.00 |
Isracann Biosciences cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Isracann Biosciences December 1, 2024 Market Strength
Market strength indicators help investors to evaluate how Isracann Biosciences pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Isracann Biosciences shares will generate the highest return on investment. By undertsting and applying Isracann Biosciences pink sheet market strength indicators, traders can identify Isracann Biosciences entry and exit signals to maximize returns
Complementary Tools for Isracann Pink Sheet analysis
When running Isracann Biosciences' price analysis, check to measure Isracann Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Isracann Biosciences is operating at the current time. Most of Isracann Biosciences' value examination focuses on studying past and present price action to predict the probability of Isracann Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Isracann Biosciences' price. Additionally, you may evaluate how the addition of Isracann Biosciences to your portfolios can decrease your overall portfolio volatility.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |